Health IT Analytics September 29, 2022
Shania Kennedy

The FDA has released new guidance recommending that some artificial intelligence-powered clinical decision support tools, like sepsis prediction devices, should be regulated as medical devices.

The Food and Drug Administration (FDA) has released new guidance stating that some artificial intelligence (AI) tools should be regulated as medical devices as part of the agency’s oversight of clinical decision support (CDS) software.

The new guidance includes a list of AI tools that should be regulated as medical devices, including devices to predict sepsis, identify patient deterioration, forecast heart failure hospitalizations, and flag patients who may be addicted to opioids, among others.

In recent years, AI and machine learning (ML) have been increasingly incorporated into medical devices because these algorithms are capable...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Medical Devices, Technology
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension
FDA approves Merck drug for rare lung disorder
Neuronetics wins FDA clearance for device to treat adolescents with depression
FDA Approves Roche’s Cobas Malaria Test, Designed to Screen for Malaria in Potential Blood Donors
Merck Drug for Heart and Lung Disorder Wins a First-in-Class FDA Approval

Share This Article